ARDELYX, INC. ARDX
- IBSRELA — Irritable Bowel Syndrome with Constipation Approved
- IBSRELA — Chronic Idiopathic Constipation Phase 3
- XPHOZAH — Hyperphosphatemia in Chronic Kidney Disease Approved
- RDX10531 Preclinical
NHE3 (1 companies · 4 programs)
Companies with an active program directed at NHE3.